United Therapeutics is trading at $523.45, up 8.72%, with no fresh company-specific announcement explaining the September 30 move identified in available coverage.
- Recent company news does not establish a direct catalyst.
- Broader sentiment may be supportive: the Nasdaq was up 0.96% and the S&P 500 was up 0.50%. United Therapeutics’ gain was substantially larger, and available evidence does not establish that market strength caused the full move.
- Intraday volume or activity data was unavailable.